Biotech / Pharma
Ten63 Therapeutics
Biotech / Pharma
Ten63 Therapeutics develops software for drug discovery that combines generative chemistry with quantum-accurate molecular simulation to design therapeutics for diseases that are currently difficult or impossible to treat with existing approaches. The company's platform, called BEYOND, simulates molecular behavior to enable rapid virtual testing of drug candidates across large chemical spaces before physical synthesis and laboratory validation.
Founded
Region
Investors
People